Literature DB >> 32432367

Enhancing tris(pyrazolyl)borate-based models of cysteine/cysteamine dioxygenases via the sterics - increased reactivities, full product characterization and hints to initial superoxide formation.

Christian Limberg1, Lars Müller2, Santina Hoof2, Matthias Keck2, Christian Herwig2.   

Abstract

The design of biomimetic model complexes for the cysteine dioxygenase (CDO) and cysteamine dioxygenase (ADO) are reported, where the 3-His coordination of the iron ion is simulated by three pyrazole donors of a trispyrazolyl borate ligand (Tp) and protected cysteine and cysteamine represent substrate ligands. It is found that the replacement of phenyl groups - attached at the 3-positions of the pyrazole units in a previous model - by mesityl residues has massive consequences, as the latter arrange to a more spacious reaction pocket. Thus, the reaction with O 2 proceeds much faster and afterwards the first structural characterization of an iron(II) h 2 - O , O -sulfinate product became possible. If one of the three Tp-mesityl groups is placed in the 5-position, an even larger reaction pocket results, which leads to yet faster rates and accumulation of a reaction intermediate at low temperatures, as shown by UV-Vis and Mössbauer spectroscopy. After comparison with the results of investigations on the cobalt analogues this intermediate is tentatively assigned to an iron(III) superoxide species.
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Spectroscopy; biomimetic models; dioxygenases; nonheme iron; reaction intermediates

Year:  2020        PMID: 32432367     DOI: 10.1002/chem.202001818

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  1 in total

1.  Nonheme iron-thiolate complexes as structural models of sulfoxide synthase active sites.

Authors:  Danushka M Ekanayake; Anne A Fischer; Maya E Elwood; Alexandra M Guzek; Sergey V Lindeman; Codrina V Popescu; Adam T Fiedler
Journal:  Dalton Trans       Date:  2020-12-22       Impact factor: 4.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.